Login / Signup

Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States.

Melissa P BeaucheminSheila Judge SantacroceKira BonaHa DangSarah AlexanderKamala AllenCrystal De Los SantosBeth FisherYudy Muñeton-CastañoOlivia PonceSarah VargasAaron SugalskiLillian SungSusan Parsons
Published in: BMC health services research (2022)
This trial was initially registered with the NCI Clinical Trial Reporting Program ID: NCI-2021-03,567 on June 16, 2021. The study can be found on clinicaltrials.gov, Identifier NCT04928599 .
Keyphrases
  • clinical trial
  • acute lymphoblastic leukemia
  • young adults
  • healthcare
  • emergency department
  • phase iii
  • quality improvement
  • acute myeloid leukemia
  • double blind
  • adverse drug
  • childhood cancer